We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
2026年临床数据证实了维生素D类似物帕立骨化醇在转移性胰腺癌中的安全性。了解其机制、结果和局限性。
